Rhumab cd 168 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Adjunctive treatment to reperfusion therapy in acute myocardial infarction or other types of reperfusion therapy (monoclonal antibody).

Rhumab cd 168 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Rhumab cd 168 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19853	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9865	58
Beijing HuaMeiHuLiBiological Chemical	010-56205725	waley188@sohu.com	China	12335	58
Shanghai YuanYe Biotechnology Co., Ltd.	13636370518	shyysw007@163.com	China	89686	60
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8000	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1578	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10308	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	7239	58
Shanghai Yifei Biotechnology Co. , Ltd.	021-65675885 18964387627	customer_service@efebio.com	China	11972	58
Wuhan Acumen Bio-Technology Co.,ltd	027-027-16602739303 16602739303	673003916@qq.com	China	4304	58

---

• Erlizumab
• Erlizumab [usan]
• Immunoglobulin G1, anti(human cd18 (antigen))F(ab')2 fragment (human-mouse monoclonal gamma1-chain), disulfide with human-mouse monoclonal light chain
• Rhumab cd 168
• Research Grade Erlizumab
• Erlizumab (anti-CD18)
• 211323-03-4